We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > granules india

News List

Granules India gets US FDA approval for Penicillamine Capsules expresspharma
December 04, 2020
They are indicated in the treatment of Wilson's disease, cystinuria, and in patients with severe, active rheumatoid arthritis.
Granules India gets US FDA approval for potassium chloride ER tablets expresspharma
October 23, 2020
Granules announced that it has received marketing approval from the US FDA for Potassium Chloride Extended Release Tablets USP, 10 mEq (750 mg) and 20 mEq (1500 mg) for the treatment of patients with hypokalemia.
Granules gets US FDA nod for OTC naproxen sodium and diphenhydramine hydrochloride tablets expresspharma
September 27, 2020
They are indicated for relief of occasional sleeplessness associated with minor aches and pains.
Granules India receives US FDA approval for Amphetamine Sulfate tablets expresspharma
August 07, 2019
The product is generic version of Arbor Pharmaceuticals LLC’s Evekeo tablets in similar strength
Granules India gets board nod to raise foreign investment limit expressbpd
July 06, 2017
The foreign investment limit has been raised to to 49 per cent